Skin Sensitivity Reported by 71% of Adults
Drug Topics
OCTOBER 28, 2022
State of Skin Sensitivity Report raises awareness of the causes of skin sensitivity and its effect on the mind.
Fri.Oct 28, 2022
464 
5 Important Things To Know About Social Media As A Resource For Pharmacy Residency Recruitment – For Both Candidates And Programs
IDStewardship
OCTOBER 28, 2022
In this article a PGY2 Infectious Diseases Pharmacy Resident discusses social media as a resource for pharmacy residency recruitment, providing insights for both programs and candidates. . Authored by: Hunter O. Rondeau, Pharm.D. Article Posted 28 October 2022. Virtual recruitment for post-graduate residency programs continues to find its place, especially now with the upcoming in-person Midyear after two years of an “online-only” environment.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
The Power of Technology in Pharmacy
Drug Topics
OCTOBER 28, 2022
The keynote address for the fall 2022 Total Pharmacy Solutions Summit looks at where independent pharmacy is and what needs to be done.
Pharma execs on creating a better workplace culture
PharmaVoice
OCTOBER 28, 2022
Top women execs speak to the leadership skills they are embracing as the industry adjusts to a new normal.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Poverty's Effects on Blood Cancer Patients
Drug Topics
OCTOBER 28, 2022
The study looked at cancer patients as a group, but senior author notes that ‘that treatments for blood cancers are very costly and many of them require treatment for long periods of time.’.
These 3 Areas of Opportunity Are Ripe for Law Changes
Pharmacy Times
OCTOBER 28, 2022
Modifications related to final product verifications, immunizations, and remote work loom on the horizon for 2023.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Experts Discuss the Future of Pharmacy Technicians Across the World
Pharmacy Times
OCTOBER 28, 2022
In a panel, pharmacy technicians discuss the future of pharmacy technicians in United States, Portugal, and the United Kingdom.
News Roundup: October 24 to October 28
Drug Topics
OCTOBER 28, 2022
Your weekly roundup of the latest news from Drug Topics®.
Cloud robotics labs are accelerating drug discovery and development
Pharmaceutical Technology
OCTOBER 28, 2022
Drug discovery and development is an incredibly expensive and time-consuming process, taking between 12 and 18 years, and costing on average between $2 billion and $3 billion. Considering the low chances of success, with only 10% of drug candidates making it into clinical development, pharma companies must prevent the increased erosion of profit margins.
Counsel Patients About Pediatric Allergy Risks, Precautions On Halloween
Pharmacy Times
OCTOBER 28, 2022
Pharmacists can remind parents to have an EpiPen on hand and to carefully review candy after trick-or-treating.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Innovative Medicines Fund and the opportunity for ICSs to mobilise NICE approvals
pharmaphorum
OCTOBER 28, 2022
In June, NHSE and NICE published details on the Innovative Medicines Fund, which will help improve patient access to cutting-edge medicines, with a particular focus on rare diseases, and ensure global pharmaceutical and biotech organisations continue to prioritise the UK as a launch destination. Join us on Wednesday 23rd November at 12:30 GMT / 13:30 CET / 7:30 am EST as the panel discuss how the Innovative Medicines Fund works, what the implications are for industry organisations in securing fu
Study: COVID-19 Vaccine Does Not Raise Immune Toxicity Risk for Those Treated With ICI
Pharmacy Times
OCTOBER 28, 2022
Findings are encouraging for individuals with cancer who are receiving immune checkpoint inhibition treatment and want to get a third vaccine dose, investigators said.
Making new product planning for life science more effective with human-centred design
pharmaphorum
OCTOBER 28, 2022
The sooner a human-centred perspective is applied to the development of either a drug or device product, the more likely the product will be adopted and used because it’s been designed around what the end consumer wants and needs. This is particularly true in the highly complex ecosystem of drug and device development, where the end consumer is only one of multiple decision-makers in the purchase process.
STAT+: How experts think we can put health data back ‘in the hands of the patient’
STAT
OCTOBER 28, 2022
Two decades ago, the Bush administration threw a wrench in health data privacy, making it possible for many health care organizations to share medical information without patients’ consent so long as it was being used to improve treatment or streamline business operations. Today, the health data marketplace looks vastly different. Medical records are being amassed by commercial data brokers and sold to insurance companies, and drug and device manufacturers, along with personal information
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Chronic Pain in NF2-SWN (Kim)
NF2 BioSolutions
OCTOBER 28, 2022
Chronic pain. I wake up in the morning & before I open my eyes I assess, has yesterday’s headache dissolved as I slept? Has the neuropathic pain in my hands & feet left the building? How about that troublesome hip & lower back pain? Oh & then there’s the facial pain. Eenie meanie miney mo…. It burns, it stabs, it sends little electric shocks shooting down my body & firing off in my foot.
Opinion: How motivational interviewing can improve health workforce well-being
STAT
OCTOBER 28, 2022
The National Academy of Medicine launched its National Plan for Health Workforce Well-Being in early October. Citing years of research defining the causes and effects of burnout in health professions, internationally recognized leaders in health care devoted two hours to a launch event for an all-hands-on-deck call to action supporting their plan, which had been developed over the course of several years by the academy’s Action Collaborative on Clinician Well-Being and Resilience.
Enabling More Efficient and Effective C&Q Through GEP
ISPE
OCTOBER 28, 2022
Enabling More Efficient and Effective C&Q Through GEP. Trudy Patterson. Fri, 10/28/2022 - 09:32. InTouch. November / December 2022. Enabling More Efficient and Effective C&Q Through GEP. Chip Bennett, PMP. Jörg Block, PhD. 1 November 2022. When the ISPE Baseline Guide Vol. 5, Commissioning & Qualification, 2 ed. was published in 2019, most of the attention was focused on the incorporation of quality risk management (QRM) into the integrated commissioning and qualification (C&Q) approach.
STAT+: Pharmalittle: Drugmaker raises price of old chemo med 10-fold amid shortages; Alnylam cites drug-price law in halting trial
STAT
OCTOBER 28, 2022
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured moment to daydream about weekend plans. Our agenda is still shaping up. For now, we plan to hang with Mrs. Pharmalot, romp with the official mascot, and search for the Great Pumpkin. And what about you? This remains a fine time to enjoy the great outdoors.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Outsourcing APIs put EU patients at risk
European Pharmaceutical Review
OCTOBER 28, 2022
A new report , Addressing Europe’s Medicine Exodus by Teva called on legislators to ensure a safer, more secure supply of essential medicines for EU patients, by cutting reliance on low-cost markets. Teva stated distant suppliers and supply chains, weakened by pressures such as inflation are at risk. Europe may not be able to guarantee a reliable supply of necessary drugs alongside rising demand.
STAT+: Up and down the ladder: The latest comings and goings
STAT
OCTOBER 28, 2022
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
Reuters Pharma 2022 – medical affairs and technology with Lance Hill
pharmaphorum
OCTOBER 28, 2022
During Reuters Pharma 2022, in Nice, France, pharmaphorum web editor Nicole Raleigh briefly spoke to Within3’s CEO Lance Hill, following his talk, “Medical affairs takes over: technologies to help unlock the power of insights and gain strategic ground”. In the video below, Hill discusses the recent fusion of people and technology and how medical affairs can bring real-world insights and real-world science to the table, as well as real-time understanding.
Opinion: STAT+: The need for regulatory grade evidence: Are you in the stadium or the sandbox?
STAT
OCTOBER 28, 2022
As real-world data (RWD) and real-world evidence (RWE) continue to share the limelight in pharmacoepidemiologic and pharmacoeconomic journals and congresses, the demand for defining RWD and RWE as well as a framework for leveraging real-world research has never been greater. One of the most pressing concerns involves what constitutes “regulatory grade” real-world data and real-world evidence, and when sponsors need to ensure that research conducted using data other than those gener
Crucial test: Labour woos big business in ‘prawn cocktail offensive 2.0’
The Guardian - Pharmaceutical Industry
OCTOBER 28, 2022
Wes Streeting and Jonathan Reynolds test water with pharma firm GSK as party takes on Rishi Sunak As Rishi Sunak emerged as the UK’s next prime minister this week, an experiment was taking place on the outskirts of Stevenage. Huddled around the fume cupboards and petri dishes of GlaxoSmithKline’s global research lab, two of Labour’s frontbench team were testing the water with big business.
Aclidinium Bromide/Formoterol, Aclidinium Bromide May Be Effective for Severe Stable COPD
Pharmacy Times
OCTOBER 28, 2022
Covis announced positive topline results for 2 new medications that can treat patients with moderate to severe stable chronic obstructive pulmonary disease.
CSafe and BioLife Solutions Partnership Will Expand Supply Chain for Cell and Gene Therapies
BioPharm
OCTOBER 28, 2022
The newly formed partnership between CSafe and BioLife will expand cold chain supply chain solutions for the cell and gene therapy market.
Cystatin C Levels May Accurately Stratify Risk of Cardiovascular Disease in Patients With Chronic Kidney Disease
Pharmacy Times
OCTOBER 28, 2022
The estimation of glomerular filtration rate based on cystatin C could provide a more robust prediction of cardiovascular disease and mortality in patients.
Vaxcyte trains its sight on a lucrative market with pneumococcal vaccine
Pharmaceutical Technology
OCTOBER 28, 2022
On 24 October, American vaccine developer Vaxcyte shared positive topline data from a Phase I/II study of its multivalent conjugate pneumococcal vaccine VAX-24 , bringing the 24-valent pneumococcal jab one step closer to market. The vaccine demonstrated a similar safety profile to Pfizer’s marketed 20-serotype shot Prevnar 20 at all assessed doses, and showed non-inferior efficacy.
Capivasertib Plus Faslodex Meets Both Primary Endpoints in Phase 3 Trial for Breast Cancer
Pharmacy Times
OCTOBER 28, 2022
Results demonstrate improved progression-free survival in the overall patient population and in a prespecified biomarker subgroup of tumors with alterations in specific genes, AstraZeneca says.
PhoreMost enters multi-target collaboration with Arvinas
Pharma Times
OCTOBER 28, 2022
PhoreMost to deploy its Siteseeker protein platform to enable drug discovery
Real-World Results of Gilead’s Biktarvy Show Long-Term Efficacy, Safety Profile
Pharmacy Times
OCTOBER 28, 2022
New clinical outcomes from BICSTaR study indicate sustained impact of the therapy for individuals with HIV.
Communities of Practice Profiles: Shaping the Future of the Combination Products Industry
ISPE
OCTOBER 28, 2022
Communities of Practice Profiles: Shaping the Future of the Combination Products Industry. Trudy Patterson. Fri, 10/28/2022 - 09:05. InTouch. November / December 2022. Communities of Practice Profiles: Shaping the Future of the Combination Products Industry. Marcy Sanford. 1 November 2022. Combination Products is one of ISPE’s newest Communities of Practice (CoPs).
Help Prevent Spread of Pink Eye
Pharmacy Times
OCTOBER 28, 2022
School can spread more than knowledge- some researchers suggest that pink eye is most commonly spread among school students.
ISPE Briefs: New GPG Explores Membrane-Based WFI Systems
ISPE
OCTOBER 28, 2022
ISPE Briefs: New GPG Explores Membrane-Based WFI Systems. Trudy Patterson. Fri, 10/28/2022 - 09:57. InTouch. November / December 2022. ISPE Briefs: New GPG Explores Membrane-Based WFI Systems. Marcy Sanford. 1 November 2022. For nearly a century, production of water for injection (WFI) was universally accepted to be distillation-based. As emphasis on costs and environmental concerns has grown, pharmacopeias around the world have focused on the quality attributes of WFI to allow for consideration
Let's personalize your content